← Eichor
Study identifier: NCT05617716 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Spine Radiosurgery for Symptomatic Metastatic Neoplasms

Condition: Metastatic Neoplasm to the Spine · Metastatic Neoplasm  ·  Sponsor: University of Oklahoma

PhasePhase 2
Planned participants240
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to compare three types of radiation therapy for cancer that has spread to the spine. The two types of radiation therapy used in this trial are External Beam Radiation Therapy (EBRT) and Stereotactic Body Radiation Therapy (SBRT). EBRT delivers tightly targeted radiation beams from outside the body. SBRT is a specialized type of radiation therapy that allows high doses of radiation to small targets. This study will include standard dose SBRT and higher dose SBRT. Each participant will be randomly assigned to either EBRT, standard dose SBRT, or higher dose SBRT.

This description comes directly from the study's public registry record.

Talk to the study team

Lead Onco Nurse  ·  405-271-8777  ·  SCC-IIT-Office@ouhsc.edu

Shearwood McClelland III, MD  ·  405-271-3016  ·  Shearwood-McClelland@ouhsc.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Johns Hopkins University HospitalsBaltimore, Maryland, United StatesActive Not Recruiting
OU Health Stephenson Cancer CenterOklahoma City, Oklahoma, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05617716